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knee pain (GRC Pain) and function (GRC Function). Analyses were performed for the whole cohort and for the two treatment groups (n=55 and 52) with adjustments for age, sex, BMI and baseline KOOS.
Results: For the whole cohort, a one-second better baseline six-meter timed hop test result was associated with 3.1-7.1 points better two-year scores for all KOOS subscales (95% CIs 1.1-5.2 to 4.1-10.1 points). A 1.61 to 2.80 s better test was associated with scores equivalent to previously calculated clinical relevant differences for each KOOS subscale. For the groups of patients treated with ET and APM respectively, 2.09-3.60 s and 0.63-1.99 s better tests were associated with clinical relevant differences.
For the whole cohort, a one-second better test was associated with 26% (95% CI 15-38%) and 22% (95% CI 11-34%) higher possibility for better or much better GRC Pain and Function scores. Patients treated with ET had 17% (95% CI 2-33%) increased possibility for better or much better GRC Pain score, and patients treated with APM had 65% (95% CI 32-108%) and 70% (95% CI 38-109%) increased possibility for better or much better GRC Pain and Function scores.
Conclusions:
The six-meter timed hop test result was a significant prognostic factor for two-year patient-reported outcomes in middle-aged patients with degenerative meniscal tears, especially in those treated with APM. 
INTRODUCTION
During the last years, the incidence of arthroscopic treatment for degenerative knee diseases has declined in Sweden and Finland [24] , and in Norway the number of meniscal resections decreased from 14.927 in 2013 to 7.979 in 2016 (data from the Norwegian Patient Registry). This trend might result from high quality randomized controlled trials (RCTs) [11, 12, 14-16, 20, 32, 33, 42] and systematic reviews [19, 37, 39] comparing patient-reported outcomes in middle-aged patients with degenerative meniscal tears, 1 to 5 years after treatment with arthroscopic partial meniscectomy (APM) or exercise therapy (ET) or sham surgery. Significant improvements in pain and function are seen following both APM and ET, but differences between treatment groups are minor [11, 12, 14-16, 20, 32, 33, 42] .
Implementation of these research findings into clinical practice is challenging [23] , and guidance for clinicians and patients for tailored interventions is limited. On an individual level, there will always be patients who get worse, those who do not change, and those who improve, regardless of type of treatment. Furthermore, prognostic factors for outcomes after APM and ET could differ. Clinicians would like to optimize clinical outcomes by identifying patients' characteristics, as well as clinical-and disease-related factors to guide treatment decisions. Stratified medicine and personalized medicine address these issues (https://www.mrc.ac.uk/research/initiatives/stratifiedmedicine/). Stratified medicine tailors care to subgroups of patients via key characteristics, disease, or biomarkers. A first step in applying these principles for patients with degenerative meniscal tears would be to identify baseline characteristics that affect the prognosis following treatment.
In the Odense-Oslo Meniscectomy versus Exercise (OMEX) trial (www.clinicaltrials.gov NCT01002794), no significant differences were found in Knee Injury and Osteoarthritis Outcome Score (KOOS) after 2 years in groups of patients treated with ET or APM [20] .
In this secondary exploratory analysis from the same trial, the hypothesis was that baseline characteristics could predict patient reported outcomes and the main objective was to identify prognostic factors for two-year outcomes for the whole cohort as well as for those treated with ET and APM separately.
MATERIALS AND METHODS
This study was a hypothesis-generating, per protocol analysis of data from the OMEX trial, a prospective RCT of middle-aged patients with degenerative medial meniscal tears treated with either a 12-week ET program or APM without concomitant ET or physiotherapy [20] . The meniscal tears were defined as "degenerative" if symptoms arose during normal physical activities without significant trauma, e.g. during walking, running or squatting. The 35-60 year-old patients had MRI-verified unilateral medial meniscal tears, no ligament injuries or locked knees and radiographic osteoarthritis (OA) grade 0-2 according to Kellgren and Lawrence (KL) [17] . KL grade 2 was defined as a definite presence of an osteophyte and possible joint space narrowing [30] .
The RCT included 140 patients and 126 (90%) completed the two-year follow up [20] .
Excluded from this secondary analysis were 16 patients who had not completed their allocated interventions (10 did not carry out the ET program according to a priori defined criteria [20] and six did not go through APM because they refused or their indications changed), five patients with OA severity of KL grade 2 or 3, four patients with incomplete baseline data, and eight patients with incomplete two-year data.
Hence, this secondary analysis is based on the 107 patients with full datasets (referred to as the "whole cohort") and on the groups treated with ET (n=55) and APM (n=52), respectively ( Figure 1 ). Post hoc analyses of baseline and outcome variables showed similar results in the groups of excluded versus included patients.
Treatment strategies
The ET program consisted of progressive neuromuscular and strength exercises over 12 weeks (2-3 sessions a week) and has previously been described in detail [35] . The APMs were performed as standard arthroscopies, with 30 degrees optics, standard portals, and lavage with Ringer acetate. Examination of joint cartilage, ligaments and menisci were followed by resection of unstable meniscal tissue. Postoperatively, the patients were mobilized with crutches for 3-4 days and given oral and written instructions for home exercises aimed at reducing symptoms and regaining normal function [20] .
Two-year outcomes
Pain and knee function at the two-year follow up were measured with the five subscales of KOOS (Pain, other Symptoms, Activities of Daily Living (ADL), Sport and Recreation (Sport/Rec) and Quality of Life (QoL) and 5-point Global Rating of Change (GRC) scales for Pain and Function. The KOOS is reliable and valid [27, 28] and study-and subscalespecific clinical relevant differences for patients included in the OMEX RCT have been reported to be 8.1, 9.2, 5.0, 11.5 and 15.1 points for Pain, Symptoms, ADL, Sport/Rec and QoL, respectively [20] . The GRC questions were: 1) "With respect to your knee disorder, how would you describe your pain now compared to when you were included in the study and started treatment?" (GRC Pain), and 2) "With respect to your knee disorder, how would you describe your knee function now compared to when you were included in the study and started treatment?" (GRC Function). The patients defined their pain and knee function from baseline to follow up as much worse, worse, unchanged, better, or much better. To identify prognostic factors for scoring pain and function at 2 years as at least better than baseline, the GRC scales were dichotomized with the cut-off between "unchanged" and "better".
Prognostic factors
Since a tear in a degenerative meniscus is regarded as the first sign of OA [10] , it is reasonable to assume that patients with higher total load of known risk factors for OA may be at higher risk of deterioration of knee pain and function compared to patients with lower total load of risk factors. Known risk factors for OA are higher age [18] , female sex [18] , higher BMI [18] , cigarette smoking [1], impaired lower extremity performance [40] , lower knee extension strength [25] , lower physical activity level [22] , higher grade of meniscal degeneration [6, 10] , more meniscal extrusion [3] and receiving APM [10] .
Knee function-related factors
Baseline scores of the five KOOS subscales, lower extremity performance tests, quadriceps muscle strength and physical activity level were included as knee functionrelated prognostic factors.
Lower extremity performance was measured by reliable and valid single-leg tests: The one-leg hop test for distance, the six-meter timed hop test and the maximum number of knee bends in 30 seconds test [7, 8, 29] . The test procedures have been described previously [34] (and the six-meter timed hop test is illustrated in Figure S1 , Supplementary appendix). Quadriceps muscle strength was measured using an isokinetic dynamometer, testing at 60 0 /second (Biodex 6000 System; Biodex Medical Systems Inc, Shirley, NY, US) [9] .
Physical activity was measured at baseline and at 2 years using two different questionnaires. At baseline the patients were asked "How many times a week (mean) do you exercise?" (frequency) and "How many hours a week (mean) do you exercise?" (duration), both questions related to the last six months before inclusion in the trial. At 2 years, additional information for physical activity was included; the activity questionnaire from a large health survey, the Nord-Trøndelag Health Study (HUNT 1) [21] . The patients were asked to report frequency, duration and intensity of physical activity on a Likert scale (Table S1 , Supplementary appendix). Each score was weighted by intensity level, and the product of the three scores gave the HUNT 1 activity index, ranging from 0 (lowest) to 15 (highest) (Table S1, Supplementary appendix) [21] .
Additionally, the patients were asked to estimate their physical activity level retrospectively over the previous 6 months prior to inclusion using the HUNT 1 activity index. Correlation analyses of baseline and two-year data on physical activity were performed to test the validity of including the retrospectively collected HUNT 1 activity index as a baseline variable. With a cut-off for acceptable correlation set to coefficients larger than 0.40, we found acceptable correlation for frequency and duration (correlation coefficients were 0.43 and 0.42, respectively). Therefore, the retrospective data (HUNT 1 activity index) collected at 2 years were accepted as baseline activity level measures.
Disease-related factors
Meniscal pathology at baseline was assessed with MRI, using grade of degeneration and amount of extrusion. Meniscal degeneration was graded (0-3b, higher is worse) [2] .
Grade 0 represents healthy meniscal tissue, grade 1 tissue degeneration inside the meniscus, grade 2 a tear not reaching the surface of the meniscus, grade 3 a tear penetrating one (3a) or both (3b) surfaces of the meniscus. Meniscal extrusion was evaluated on the coronal sequence image with the largest tibial spine volume and defined as meniscal subluxation crossing a vertical line on the medial margin of the tibia without osteophytes. Extrusion was given in per cent (width of extruded meniscal tissue relative to the total width of the meniscus in the same image, higher is worse) [13] ( Figure S2 , Supplementary appendix).
Statistical analyses
The statistical computation was performed using IBM SPSS Statistics version 25 (IBM Comparison between groups was not part of this study; hence, no statistical analysis was performed to evaluate group differences (Table 1) . General assessments of fulfilment of the statistical methods' underlying assumptions were made. The estimation uncertainty of regression parameter estimates is presented in terms of 95% confidence intervals (95% CIs) and p-values <0.050 were considered statistically significant.
Multiple linear regression models were built for the five continuous KOOS subscale outcomes. For interpretation of the results of the linear regression analyses, the previously calculated clinical relevant differences of each KOOS subscale [20] were used to calculate the exact level of independent variables needed to achieve the actual KOOS values. Poisson regression models, including the Hubert-White estimator, were built for the two dichotomized GRC outcomes (Pain and Function). This estimator provides asymptotically consistent estimates of the covariance matrix for parameter estimates without any distributional assumptions and even when the assumed model underlying the parameter is incorrect [41] . The analyses were performed for the whole cohort and repeated for the respective treatment groups. Hence, 21 regression models were analysed in total. Due to the exploratory nature of this secondary study adjustments for multiplicity was not included because they are usually not considered meaningful [4] .
Statistical models for confounding adjustment were based upon clinical experience and literature studies [1, 3, 5, 10, 18, 22, 25, 40] . Additionally, Diagnostic Acyclic Graphs (DAGs) were generated with DAGitty (http://www.dagitty.net) [38] (Figure S3 , Supplementary appendix) in order to define the statistical models that best reduced confounding while avoiding both adjustment bias and collider stratification bias [31] .
Hence, age, sex, BMI and baseline KOOS for each subscale were identified as potential confounders.
RESULTS
Descriptive data including demographics, prognostic factors and two-year outcomes for the whole cohort and for the two treatment groups separately are presented in Table 1 .
Results of the regression analyses are presented in Table 2 . The six-meter timed hop test at baseline associated with clinical relevant outcomes after 2 years are presented in Table 3 .
For the whole cohort (n=107), a one-second better hop test result was associated with 3.1 to 7.1 points better two-year scores for all five KOOS subscales (95% CI ranging from 1.1-5.2 to 4.1-10.1 points, and 26% (95% CI 15-38%) and 22% (95% CI 11-34%) increased possibility for scoring better or much better for GRC Pain and Function, respectively ( Table 2) . A 1.61-2.80 s better test was associated with two-year scores equivalent to the previously calculated clinical relevant differences for each KOOS subscale (Table 3) .
For patients treated with ET (n=55), a one-second better hop test result was associated with better KOOS Symptoms, Sport/Rec and QoL (2.6-5.5 points, 95% CI from 0.2-4.9 to 2.1-9.0 points) and 17% (95% CI 2-33%) higher risk for better or much better GRC Pain score ( Table 2) . A 2.09-3.60 s better hop test was associated with clinical relevant differences ( Table 3) .
For patients treated with APM (n=52), a one-second better hop test result was associated with better KOOS Pain, ADL, Sport/Rec and QoL (7.6 to 11.0 points, 95% CI from 3.0-12.3 to 4.9 -17.0) and 65% (95% CI 32-108%) and 70% (95% CI 38-109%) higher risk for better or much better GRC Pain and Function scores, respectively (Table   2 ). A 0.63-1.99 s better test was associated with clinical relevant differences (Table 3 ).
Higher activity level measured with the HUNT 1 activity index was associated with 64% (95% CI 7-153%) and 83% (95% CI 4-223%) increased possibility for better or much better GRC Pain and Function scores, respectively (Table 2) .
DISCUSSION
The principal finding of this study was that better knee performance at baseline measured with the six-meter timed hop test was a significant prognostic factor for less knee pain and better knee function after 2 years. Patients treated with APM had almost four times higher possibility for scoring better or much better in GRC Pain than patients treated with ET (65% versus 17%), and smaller differences in hop test results at baseline were associated with clinical relevant KOOS results [20] at 2 years (0.63-1.99 s versus 2.09-3.60 s).
To our knowledge, the six-meter timed hop test has not previously been used for middle-aged patients with degenerative meniscal tears, and psychometric properties of the test for this patient group is unknown. Mean hop time has been reported to be 1.82-1.86 s (SD 0.17-0.22 s) for young, healthy males [29] and 2.3 s (SD 0.2 s) for anterior cruciate ligament (ACL)-reconstructed patients after rehabilitation [36] . Our cohort used more time (2.84 s) and had a larger coefficient of variation compared to these populations (54% vs. 9-12%) [29, 36] . In our study, those who had the highest performance (the best quartile) had a mean hop time of 1.77 s (SD 0.17 s), and the second, third and forth quartile had a mean hop time of 2.21 s (SD 0.14 s), 2.83 s (SD 0.22 s) and 4.62 s (SD 2.23 s), respectively (Table S2 , Supplementary appendix). Thus, one out of four middle-aged patients with degenerative meniscal tears hopped better or as well as young healthy males, and about half of the patients hopped better than ACLreconstructed patients. However, this study show that those with a hop time of the timeframe of 3.29 to 12.47 s (the lower quartile) should be informed that they would have better prognoses for outcomes if they improve their knee performance.
Another finding was that higher activity level at baseline was prognostic for outcomes in patients treated with APM, but not ET. Consequently, patients should be encouraged to increased physical activity level or either prior to or following surgery.
Higher physical activity level at baseline (HUNT 1 activity index) was a prognostic factor for patients treated with APM, but not ET. Consequently, patients treated with APM should be encouraged to increase their physical activity level. In patients treated with APM, better maximum knee bends in 30 s test was associated with better Symptoms, but the association was weak (0ne second associated with 0.6 more bends) and of no clinical interest.
This study has some limitations. First, this study does not include radiographs appropriate for evaluation of varus-valgus alignment. Second, MRI-evaluation included degeneration grade (0-3b, lower is better) [2] and measurement of meniscal extrusion [13] . More extensive classification systems as e.g. WORMS [26] might have strengthened our study. Third, in the subgroup analyses of GRC Pain and Function, reduced samples, especially for the APM-group, might have led to spurious results reflected in the wide 95% CIs. Forth, the external validity of this study might be weakened by the fact that these participants were highly educated, had higher activity levels than a younger (20-39 years old) Norwegian county population [21] , were also only slightly over weighted (BMI 25.7) and only 7.5% reported daily smoking. Assumingly, these patients might have been more prone to accept being included in a scientific trial including ET than less educated and less fit individuals.
To our knowledge, this is the first study to examine prognostic factors for patientreported outcomes of pain and function in middle-aged individuals with degenerative meniscal tears without radiological knee OA. A degenerative meniscal tear is an early sign of knee OA [10] and identification of prognostic factors for outcomes available before OA is established might be a supplement to other risk-related factors such as high BMI [18] , weak quadriceps muscle strength [25] and poor knee function [40] . This lowcost and quickly performed test is easily implemented in a clinical setting, and may give valuable information on future risk of worse knee pain and impaired knee function.
Conclusion
In patients with degenerative meniscal tears, a better six-meter timed hop test result at baseline was a significant prognostic factor for better patient-reported knee function after 2 years, especially in those treated with APM. 
